Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy

@article{Mazzuferi2013Nrf2DP,
  title={Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy},
  author={M. Mazzuferi and G. Kumar and J. Eyll and B. Danis and P. Foerch and R. Kaminski},
  journal={Annals of Neurology},
  year={2013},
  volume={74}
}
Epigenetic mechanisms involved in transcriptional regulation of multiple molecular pathways are potentially attractive therapeutic interventions for epilepsy, because single target therapies are unlikely to provide both anticonvulsant and disease‐modifying effects. 
Overview of Nrf2 as Therapeutic Target in Epilepsy
TLDR
The aim of this review is to present experimental evidence on the role of Nrf2 in this neurological disorder and to further determine the therapeutic impact of NRF2 in epilepsy. Expand
Nrf2 to the Rescue
TLDR
A clear rationale exists for validating the Nrf2 pathway as antiepileptic or antIEpileptogenic therapies, and a significant twofold NRF2 Defense Pathway is revealed: Experimental Evidence for its Protective Role in Epilepsy. Expand
Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies
TLDR
The up‐to‐date experimental and clinical evidence that supports the neuromodulatory role of inflammatory mediators, their related signaling pathways, and involvement in epilepsy are reported on. Expand
Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)
TLDR
The authors review recent progress of covalent activators and non-covalent Keap1-Nrf2 protein-protein interaction (PPI) inhibitors from patents and publications in 2017-present, consisting of new chemical molecules, structure optimization of reported activator and progress in preclinical or clinical trials. Expand
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders.
TLDR
Current studies of sulforaphane-mediated Nrf2 activation in the treatment of various neurological disorders are recapitulate, which shows potential in regulating the series of cytoprotective enzyme expressions that have neuroprotective, antioxidative, and detoxification actions. Expand
Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis
TLDR
Preventing the progression of epilepsy by targeting Nrf2-activated antioxidant pathway along with the other established antiepileptic pathways can prove beneficial in epilepsy treatment. Expand
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors.
TLDR
This review summarizes peptide and small molecule Keap1-Nrf2 inhibitors reported recently and highlights the pharmacological effects and discusses the possible therapeutic application of Keap2-NRF2 inhibitors. Expand
Rosiglitazone Prevents Autophagy by Regulating Nrf2-Antioxidant Response Element in a Rat Model of Lithium-pilocarpine-induced Status Epilepticus
TLDR
It is found that rosiglitazone markedly improved neuronal survival at 24-h post-SE and attenuates oxidative-stress-induced autophagy via increasing Nrf2 in SE rats and may be used as a promising therapeutic strategy for SE treatment. Expand
Identifying key regulators of the immune/inflammatory response for developing anticonvulsive and antiepileptogenic approaches
TLDR
Pro-resolving and anti-inflammatory treatments have disease-modifying effects and HMGB1 isoforms are potential mechanistic biomarkers for epileptogenesis, underlying the need of validation in prospective clinical studies. Expand
A Metabolic Paradigm for Epilepsy
TLDR
A metabolic paradigm for epilepsy rests upon known perturbations in three major interconnected metabolic nodes and therapeutic targets therefrom (i.e., glycolysis, mitochondria, and redox balance). Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?
  • I. Copple
  • Biology, Medicine
  • Advances in pharmacology
  • 2012
TLDR
Historical and recent advances in understanding of the molecular mechanisms that regulate the activity of the Keap1-Nrf2 pathway are highlighted, alongside the emerging role of Nrf2 in promoting oncogenesis and chemotherapeutic drug resistance. Expand
Antiepileptogenesis and Seizure Prevention Trials with Antiepileptic Drugs: Meta‐Analysis of Controlled Trials
TLDR
Evidence concerning the effect of antiepileptic drugs (AEDs) for seizure prevention and to contrast their effectiveness for provoked versus unprovoked seizures are synthesized. Expand
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
TLDR
There is a need to summarize the current literature on phase II genes in the central nervous system (CNS) to help guide future studies on phase I, II and III genes as therapeutic targets in neurological diseases. Expand
Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.
TLDR
The dysregulation of Nrf2-regulated genes provides a logical explanation for the connections between observable oxidative stress and perhaps 200 human diseases involving these various physiological processes, each reflecting a network involving many gene products. Expand
An important role of Nrf2-ARE pathway in the cellular defense mechanism.
TLDR
The function of Nrf2 and its downstream target genes suggests that the NRF2-ARE pathway is important in the cellular antioxidant defense system, and may serve as a therapeutic target for neurodegenerative diseases and cancers, in which oxidative stress is closely implicated. Expand
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
TLDR
Stark results indicate that Nrf2 expression restricted to astrocytes is sufficient to protect against MPTP andAstrocytic modulation of the NRF2-ARE pathway is a promising target for therapeutics aimed at reducing or preventing neuronal death in PD. Expand
Neuronal sensitivity to kainic acid is dependent on the Nrf2‐mediated actions of the antioxidant response element
TLDR
A role for Nrf2 in the neural cell defense response of the adult brain is supported, as evidenced by elevated seizure severity, seizure duration, hippocampal neuron damage and mortality, and genetic changes to the cellular reducing potential may reflect an intrinsic damage response to harmful toxicants. Expand
Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
TLDR
It is suggested that HO-1 does not protect or enhance the sensitivity to neuronal death in Parkinson's disease and that pharmacological or genetic intervention on Nrf2 may provide a neuroprotective benefit as add on therapy with current symptomatic protocols. Expand
The methylation hypothesis: Do epigenetic chromatin modifications play a role in epileptogenesis?
TLDR
The methylation hypothesis suggests that seizures by themselves can induce epigenetic chromatin modifications, thereby aggravating the epileptogenic condition. Expand
Beneficial Effects of Nrf2 Overexpression in a Mouse Model of Alexander Disease
TLDR
The data suggest that the beneficial effects of Nrf2 are not mediated through glutathione, and that the neuroprotective effects ofNrf2 in other neurological disorders may reflect restoration of glutATHione to normal levels. Expand
...
1
2
3
4
5
...